China Resources Medical Holdings 관리
관리 기준 확인 0/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Hai Yu
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 1.8yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 1.8yrs |
| 이사회 평균 재임 기간 | 2.5yrs |
최근 관리 업데이트
Recent updates
Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down
Nov 14
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher
Oct 02We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings
May 06China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Apr 26Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price
Mar 09Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?
Nov 29China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall
Oct 19Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Aug 30Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?
Aug 26China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Jun 30China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
May 12Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)
Apr 03Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Feb 21China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital
Jan 10We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Nov 30Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?
Oct 18China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends
Sep 21Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?
Jul 13Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Jun 24China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12
Jun 03China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12
Apr 27We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Apr 22Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%
Mar 30Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?
Jan 27China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jan 03China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
Nov 19Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Oct 26An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued
Sep 20Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly
Sep 06China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively
Aug 17Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Jun 21China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate
Jun 09Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality
May 03China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?
Apr 22We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt
Mar 27CEO
Hai Yu (56 yo)
1.8yrs
테뉴어
Mr. Hai Yu is Chief Executive Officer & Executive Director of China Resources Medical Holdings Company Limited from February 27, 2023. He is the general manager of China Resources Health Group Limited, and...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| VP & Executive Director | 2.9yrs | CN¥3.24m | 데이터 없음 | |
| Executive Chairman of the Board | 6.3yrs | CN¥71.00k | 0.031% HK$ 1.5m | |
| CEO & Executive Director | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| CFO & Executive Director | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Company Secretary | less than a year | 데이터 없음 | 데이터 없음 |
1.8yrs
평균 재임 기간
53yo
평균 연령
경험이 풍부한 관리: 1515 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| VP & Executive Director | 3.3yrs | CN¥3.24m | 데이터 없음 | |
| Executive Chairman of the Board | 6.3yrs | CN¥71.00k | 0.031% HK$ 1.5m | |
| CEO & Executive Director | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| CFO & Executive Director | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Honorary Chairman | 8yrs | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 6.3yrs | CN¥257.00k | 데이터 없음 | |
| Independent Non-Executive Director | 11.2yrs | CN¥257.00k | 데이터 없음 | |
| Non-Executive Director | 1.2yrs | 데이터 없음 | 0.0051% HK$ 245.5k | |
| Independent Non-Executive Director | 1.2yrs | CN¥81.00k | 데이터 없음 |
2.5yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 이사회: 1515 의 이사회는 경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.